• English
  • Sign In
  • Contact Us
Catalog Products » Other Products » Endotoxin Detection and Removal System » Endotoxin Detection » ToxinEraserTM Endotoxin Removal Kit

ToxinEraser™ Endotoxin Removal Kit

Description Lipopolysaccharide (LPS) is a bacterial endotoxin, and a major constituent of the cell walls of gram-negative bacteria. During gram-negative bacteremia or endotoxemia, LPS is the principal pathophysiological mediator by which bacteria can cause hypotension, organ failure, disseminated intravascular coagulation, and fatal shock in mammalian hosts. The removal of these endotoxins is highly necessary for downstream processes but also highly difficult.

GenScript ToxinEraser is an endototoxin removal resin of high efficiency. It is based on the affinity matrix of modified polymyxin B (PMB),which allows highly efficient endotoxin removal. The final endotoxin level can be decreased to as low as 0.1 EU/ml * with repeat use of ToxinEraserTM endotoxin removal resin. * final removal efficiency may vary depending on the sample type/source.

Key Features
Key Features

  • High stability and high removal efficiency
  • High binding capacity: > 2,000,000 EU/ml (CV)
  • Fast flow without any constant speed pump
  • Reusable up to five times if properly regenerated
  • Ready-to-use reagents and materials, such as equilibration buffer, collection tubes, etc.

Storage For storage of the column, wash the column with 10 ml of equilibration buffer and allow the column to drain completely. Add 1.5 ml of regeneration buffer supplemented with 0.02% sodium azide. Store at 2°C to 8°C. Do not freeze.

Cat. No. Product Name Quantity Price
ToxinEraser™ Endotoxin Removal Resin - 1 ml
ToxinSensor™ Gel Clot Endotoxin Assay Kit - 1 kit
ToxinSensor™ Chromogenic LAL Endotoxin Assay Kit - 1 Kit (16 rxns)
ToxinSensor™ Endotoxin-free Pipette Tips (1 ml, Blue) - 1 PK of 6 tips
ToxinSensor™ Endotoxin-free Tubes - 10 Tubes
ToxinEraser™ Regeneration Buffer - 125 ml
ToxinEraser™ Equilibration Buffer - 125 ml
Ntumngia FB, et al. Immunogenicity of a synthetic vaccine based on the Plasmodium vivax Duffy Binding Protein Region II. Clin Vaccine Immunol. 2014June;

N Chen, et al. Study on the immune response to recombinant Hsp70 protein from Megalobrama amblycephala. Immunobiology. 2014July;

W Li, et al. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice. Mol Immunol. 2014Nov.;62(1):86–95

Y Liu, et al. Mucosal immunization with recombinant fusion protein DnaJ-ΔA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via IL-17A. Infect Immun. 2014Feb.;

BK Ko, et al. Combination of novel HER2 targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2 positive gastric cancer. Mol Oncol. 2014Sep.;

Lai CH, et al. Sensitization of radio-resistant prostate cancer cells with a unique cytolethal distending toxin. Oncotarget. 2014July;5(14):5523-34

Zhou QJ, et al. Expression of Caenorhabditis elegans-expressed Trans-HPS, partial aminopeptidase H11 from Haemonchus contortus. Exp Parasitol. 2014Aug.;145C87-98

W Gong, et al. Surface protein Adr2 of< i> Rickettsia rickettsii</i> induced protective immunity against Rocky Mountain spotted fever in C3H/HeN mice. Vaccine. 2014Feb.;

He X, et al. Anti-lyssaviral activity of interferon κ and ω from the Serotine bat, Eptesicus serotinus. J Virol. 2014Feb.;

You can visit "Citations Database" for more citations.

For more documents, please visit "Technical Support".

Cat. No. L00338
Size Price
1 kit $126.00